Transpek Industry Ltd
Incorporated in 1965, Transpek Industry Limited is into the manufacturing and export of a range of chemicals servicing the requirements of customers from a diverse range of industries including Textiles, Pharmaceuticals, Agrochemicals, Advanced Polymers, etc. [1]
- Market Cap ₹ 889 Cr.
- Current Price ₹ 1,592
- High / Low ₹ 2,086 / 1,330
- Stock P/E 12.3
- Book Value ₹ 932
- Dividend Yield 1.41 %
- ROCE 17.8 %
- ROE 15.9 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
184 | 156 | 211 | 241 | 259 | 284 | 317 | 361 | 595 | 566 | 339 | 599 | 767 | |
154 | 156 | 185 | 218 | 228 | 236 | 263 | 314 | 478 | 447 | 292 | 499 | 643 | |
Operating Profit | 30 | 0 | 26 | 23 | 31 | 48 | 53 | 47 | 117 | 118 | 47 | 100 | 123 |
OPM % | 16% | 0% | 12% | 10% | 12% | 17% | 17% | 13% | 20% | 21% | 14% | 17% | 16% |
1 | 4 | 3 | 7 | 5 | 2 | 7 | 10 | 18 | 17 | 17 | 24 | 16 | |
Interest | 7 | 10 | 11 | 12 | 12 | 11 | 9 | 12 | 19 | 16 | 10 | 11 | 16 |
Depreciation | 7 | 7 | 7 | 7 | 9 | 8 | 9 | 10 | 14 | 26 | 29 | 30 | 32 |
Profit before tax | 17 | -12 | 11 | 12 | 16 | 32 | 42 | 35 | 101 | 94 | 26 | 84 | 91 |
Tax % | 25% | 17% | 7% | 39% | 30% | 33% | 29% | 25% | 35% | 22% | 9% | 22% | |
Net Profit | 13 | -10 | 10 | 7 | 11 | 21 | 30 | 26 | 66 | 73 | 23 | 65 | 72 |
EPS in Rs | 21.76 | -17.57 | 17.42 | 12.26 | 18.84 | 36.24 | 53.67 | 47.26 | 117.70 | 130.59 | 41.73 | 117.09 | 129.66 |
Dividend Payout % | 18% | 0% | 17% | 20% | 27% | 21% | 17% | 19% | 17% | 10% | 18% | 19% |
Compounded Sales Growth | |
---|---|
10 Years: | 14% |
5 Years: | 14% |
3 Years: | 0% |
TTM: | 39% |
Compounded Profit Growth | |
---|---|
10 Years: | 24% |
5 Years: | 18% |
3 Years: | 1% |
TTM: | 11% |
Stock Price CAGR | |
---|---|
10 Years: | 36% |
5 Years: | 5% |
3 Years: | 10% |
1 Year: | -21% |
Return on Equity | |
---|---|
10 Years: | 17% |
5 Years: | 16% |
3 Years: | 15% |
Last Year: | 16% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Sep 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | |
Reserves | 58 | 48 | 56 | 61 | 69 | 85 | 200 | 241 | 306 | 333 | 374 | 479 | 515 |
64 | 63 | 87 | 85 | 77 | 64 | 88 | 203 | 144 | 126 | 111 | 137 | 179 | |
56 | 74 | 52 | 72 | 76 | 54 | 93 | 116 | 143 | 124 | 108 | 143 | 170 | |
Total Liabilities | 184 | 190 | 200 | 225 | 229 | 209 | 386 | 566 | 599 | 589 | 599 | 764 | 870 |
89 | 93 | 95 | 93 | 92 | 94 | 117 | 179 | 236 | 287 | 287 | 295 | 349 | |
CWIP | 5 | 1 | 2 | 4 | 5 | 10 | 13 | 56 | 33 | 19 | 14 | 16 | 24 |
Investments | 13 | 11 | 14 | 9 | 5 | 5 | 131 | 144 | 149 | 118 | 142 | 196 | 212 |
77 | 85 | 90 | 118 | 126 | 100 | 125 | 188 | 180 | 165 | 156 | 258 | 285 | |
Total Assets | 184 | 190 | 200 | 225 | 229 | 209 | 386 | 566 | 599 | 589 | 599 | 764 | 870 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
30 | 16 | 19 | 19 | 10 | 44 | 47 | 7 | 128 | 111 | 34 | 47 | |
-37 | -5 | -8 | -6 | -1 | -16 | -31 | -103 | -45 | -33 | -17 | -70 | |
7 | -11 | -10 | -13 | -8 | -27 | -17 | 96 | -83 | -77 | -3 | 9 | |
Net Cash Flow | 0 | 0 | 0 | -0 | 0 | 1 | -1 | 0 | -0 | 0 | 15 | -14 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 63 | 90 | 89 | 103 | 115 | 59 | 78 | 94 | 57 | 58 | 82 | 60 |
Inventory Days | 130 | 131 | 90 | 81 | 77 | 111 | 91 | 87 | 68 | 70 | 82 | 77 |
Days Payable | 130 | 212 | 105 | 129 | 128 | 60 | 83 | 103 | 72 | 73 | 81 | 65 |
Cash Conversion Cycle | 63 | 9 | 74 | 56 | 64 | 111 | 85 | 78 | 54 | 54 | 84 | 72 |
Working Capital Days | 30 | 50 | 36 | 32 | 72 | 62 | 62 | 88 | 43 | 41 | 91 | 75 |
ROCE % | 21% | -2% | 17% | 16% | 18% | 28% | 23% | 13% | 27% | 24% | 7% | 18% |
Documents
Announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 2d
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 14 Mar
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 6 Mar
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
21 Feb - Transcript of the Investor Call held on 17/02/2023.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
17 Feb - Audio Recording of the Investor Call available on website of the Company viz. www.transpek.com.
Annual reports
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2010
from bse
Concalls
-
Feb 2023Transcript PPT
-
Nov 2022TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
-
Sep 2022Transcript PPT
-
Jun 2022TranscriptNotesPPT
-
Jun 2022TranscriptNotesPPT
-
Mar 2022Transcript PPT
-
Feb 2022TranscriptNotesPPT
-
Dec 2021TranscriptNotesPPT
-
Aug 2021Transcript PPT
-
Jun 2021TranscriptNotesPPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Sep 2020TranscriptNotesPPT
Product Portfolio
The Co. manufactures chlorinated products for the supply of intermediates and specialty chemicals suitable for multiple applications consisting of Specialty Chemicals, Surfactants, Agrochemicals, Dyes, Polymers, and Pharma. [1]